This article discusses the FDA's recommendation that drugmakers update their Covid booster shots to target the predominant coronavirus strain in the US, XBB.1.5. The current vaccines still contain the original coronavirus strain, but the FDA is encouraging drugmakers to update their vaccines to ensure the best protection against the virus. The agency is also working with the CDC to ensure that the vaccines are distributed to those who need them.
Posts tagged as “Related Biological Products Advisory Committee”
The US Food and Drug Administration (FDA) is close to approving the first nation's RSV vaccine, developed by Pfizer, which has been shown to reduce the risk of illness from RSV by as much as 86%. The Vaccines and Related Biological Products Advisory Committee voted 7-4 in favor of the vaccine, despite some safety concerns. If approved, the vaccine would be the first of its kind in the US and provide a much-needed protection against RSV for older adults.